期刊文献+

关于多中心临床研究伦理审查模式的思考 被引量:12

Reflections on Ethical Review Mode of Multi-center Clinical Research
下载PDF
导出
摘要 从多中心临床研究的现状分析入手,结合最新出台的临床研究管理相关政策和要求,对比美国多中心伦理审查的实践经验,针对我国开展多中心伦理审查的模式提出建议和意见。认为当前我国多中心伦理审查应该采取有条件的“认可”组长单位审查决定的模式,逐步建立单一中心伦理审查的模式,选择最优的主审伦理委员会。区域伦理委员会在多中心伦理审查模式中可以逐步承担起主审伦理的职责,最终为解决完善伦理审查机制、提高伦理审查效率做出贡献。 Based on the analysis of the current situation of multi-center clinical research and the latest policies and requirements, and comparasion with the practical experience of multi-center ethical review in the United States, this paper puts forward suggestions and opinions on the mode of multi-center ethical review in China. It proposes that the multi-center ethical review should adopt the mode of conditional "approval" of the leading site's ethical review decision, gradually establish the mode of single IRB review, and select the best ethical committee. Regional ethics committees can gradually take the responsibility of primary review in the multi-center ethics review model, and ultimately contribute to improving the ethics review mechanism and the efficiency of ethics review.
作者 陆麒 伍蓉 LU Qi;WU Rong(Office of Ethics Committee, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China)
出处 《医学与哲学》 2019年第13期28-31,共4页 Medicine and Philosophy
关键词 多中心伦理审查 协作审查 单一伦理审查 区域伦理委员会 ethical review of multi-center research cooperative review single IRB review regional IRB
  • 相关文献

参考文献5

二级参考文献26

  • 1Anon. Multicenter Trial[EB/OL]. [2011-04-01]. http://en. wikipedia.org/wiki/M ulticenter_trial.
  • 2国际多中心临床试验研讨会将于12月9日至10日在上海召开[EB/OL].[2011-04-01].http://www.scrcnet.org/cnews.asp?id=87.
  • 3于晓蓉.美国辉瑞拿患儿做新药试验制药巨头终成被告[EB/OL].(20010915)[2011-04-11].http://finance.sina.com.cn/j/20010915/107638.html.
  • 4新文化报.美国辉瑞公司药物试验致11名儿童死亡[EB/OL].(2009-07-31)[2011-04-01].http://news.ifeng.com/society/2/200907/0731_344_1277892.shtml.
  • 5Anon. About the Bioethics Program [EB/OL].[2011-04-01]. http://www. unesco. org/new/en/social-- and -- human -- se ences/ themes/bioethics/about-bioethics/.
  • 6国际医学科学组织理事会,世界卫生组织.涉及人的生物医学研究国际伦理准则[R].陈元方,译,胡庆澧,校.日内瓦:世界卫生组织,2002:15.
  • 7US DHHS & FDA. Using a centralized IRB review process inmulticenter clinical trial [ EB/OL] . ( 2006 -03). http ://www.fda. gov/Regulatory Information/Guidances/ucml 27004. html.
  • 8国家食品药品监督管理局.关于印发“药物临床试验伦理审査工作指导原则”的通知[EB/OL]. (2010 - 11 -02). ht-tp://www. sda. gov. cn/WS01/CL0055/55613. html.
  • 9熊宁宁,李煜,汪秀琴,等.临床试验机构伦理委员会操作规程[M].科学出版社,2012:37 -42.
  • 10SILBERMAN G, KAHN KL. Burdens on research imposed byinstitutional review boards : the state of the evidence and its im-plications for regulatory reform [ J ]. Milbank Q, 2011,89 (4):599 -627.

共引文献46

同被引文献93

引证文献12

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部